CD44 and head and neck squamous cell carcinoma: CSCs have been shown to be generally more resistant to therapy and our results support the idea that CD44+ non‐responding HNSCC cell lines may also exhibit enhanced resistance to immune mediated killing, thereby increasing their chances of evading the innate immune surveillance, and overall favor their chances of metastatic dissemination.